Using cytosine deaminases to diminish retroelement transfer from pigs to humans
Details for Australian Patent Application No. 2006262020 (hide)
International Classifications
Event Publications
31 January 2008 PCT application entered the National Phase
PCT publication WO2007/002372 Priority application(s): WO2007/002372
23 December 2010 Application Accepted
Published as AU-B-2006262020
17 February 2011 Corrigenda
Applications Accepted - Name Index Under the name Regents of The University of Minnesota, Application No. 2006262020, under INID (71) correct the applicant name to Recombinetics, Inc.
21 April 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006262021-Use of mutant Herpes Simplex Virus-2 for cancer therapy
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser